Literature DB >> 21861835

Hypertension in the elderly: an evidence-based review.

A Virdis1, R M Bruno, M Fritsch Neves, G Bernini, S Taddei, L Ghiadoni.   

Abstract

The progressive ageing of world population, and the increasing prevalence hypertension in elderly people are leading to the consideration that hypertension in the elderly is one of the main topic in hypertension treatment. Multiple mechanisms, including stiffening of large arteries, endothelial dysfunction, cardiac remodeling, autonomic dysregulation, renal aspects, contribute to the great prevalence of hypertension in the elderly and to increased cardiovascular morbidity and mortality. Treatment of hypertension can hardly put back older patients in a low risk category, especially if target organ damage is present. Nevertheless, blood pressure control can successfully prevent stroke, cognitive decline, coronary heart disease and heart failure, and reduce mortality in the elderly, and even in patients > 80 years, as recently demonstrated. Blood pressure should be lowered below 140/90 mmHg also in older patients. However the HYVET study suggests that a goal of 150/90 mmHg can be reasonable in patients aged 80 years or more. Drug treatment should be titrated with particular caution to adverse responses and excessive blood pressure lowering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861835     DOI: 10.2174/138161211798157711

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Health status and risk indicator trends of the aging US health care workforce.

Authors:  David J Lee; Lora E Fleming; William G LeBlanc; Kristopher L Arheart; Kenneth F Ferraro; Marcie Pitt-Catsouphes; Carles Muntaner; Cristina A Fernandez; Alberto J Caban-Martinez; Evelyn P Davila; Frank C Bandiera; John E Lewis; Diana Kachan
Journal:  J Occup Environ Med       Date:  2012-04       Impact factor: 2.162

2.  Arterial Stiffness and Vascular Aging: From Pathophysiology to Treatment, with a Look at the Future.

Authors:  Agostino Virdis
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-02-22

3.  Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age.

Authors:  Suttira Intapad; F Lee Tull; Andrew D Brown; John Henry Dasinger; Norma B Ojeda; Joel M Fahling; Barbara T Alexander
Journal:  Hypertension       Date:  2013-02-19       Impact factor: 10.190

4.  Does Age Matter? Association Between Usual Source of Care and Hypertension Control in the US Population: Data From NHANES 2007-2012.

Authors:  John M Dinkler; Catherine A Sugar; José J Escarce; Michael K Ong; Carol M Mangione
Journal:  Am J Hypertens       Date:  2016-02-16       Impact factor: 2.689

Review 5.  2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network.

Authors:  Kazuomi Kario; Sungha Park; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-09       Impact factor: 3.738

6.  Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis.

Authors:  Edyta Zbroch; Dominika Musialowska; Ewa Koc-Zorawska; Jolanta Malyszko
Journal:  Clin Interv Aging       Date:  2016-10-28       Impact factor: 4.458

7.  Arterial-ventricular coupling and parameters of vascular stiffness in hypertensive patients: Role of gender.

Authors:  Luca Faconti; Rosa Maria Bruno; Simona Buralli; Marta Barzacchi; Elisa Dal Canto; Lorenzo Ghiadoni; Stefano Taddei
Journal:  JRSM Cardiovasc Dis       Date:  2017-02-01

8.  Genetic Background of Hypertension in Connective Tissue Diseases.

Authors:  Bogna Grygiel-Górniak; Iwona Ziółkowska-Suchanek; Elżbieta Kaczmarek; Mariusz Puszczewicz; Natalia Rozwadowska
Journal:  J Immunol Res       Date:  2020-02-03       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.